Shopping Cart
- Remove All
- Your shopping cart is currently empty
Atractylenolide III (ICodonolactone) may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury. Atractylenolide III is a potential candidate for the treatment of human lung carcinoma by inducing the release of cytochrome c, upregulating the expression of Bax and translocating apoptosis-inducing factor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $36 | In Stock | |
5 mg | $64 | In Stock | |
10 mg | $97 | In Stock | |
25 mg | $158 | In Stock | |
50 mg | $232 | In Stock | |
100 mg | $343 | In Stock | |
1 mL x 10 mM (in DMSO) | $71 | In Stock |
Description | Atractylenolide III (ICodonolactone) may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury. Atractylenolide III is a potential candidate for the treatment of human lung carcinoma by inducing the release of cytochrome c, upregulating the expression of Bax and translocating apoptosis-inducing factor. |
Alias | ICodonolactone, 8β-Hydroxyasterolide |
Molecular Weight | 248.32 |
Formula | C15H20O3 |
Cas No. | 73030-71-4 |
Smiles | CC1=C2C[C@H]3C(=C)CCC[C@]3(C)C[C@]2(O)OC1=O |
Relative Density. | 1.18 g/cm3 |
Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | Chloroform, Dichloromethane, Ethyl Acetate, Acetone: Soluble DMSO: 46 mg/mL (185.2 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.